Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMS Giotto is an Italian medical technology company specializing in the design and manufacture of advanced breast imaging systems. Founded in 1965, the company is a pioneer in digital mammography and breast tomosynthesis, offering a range of products including the Giotto Class and Giotto Image series. Their systems are known for unique features like the ring-shaped gantry and tilting capabilities that improve patient comfort and clinical accuracy. Now part of the GMM Group, IMS Giotto continues to innovate in the fields of 2D/3D mammography, contrast-enhanced mammography (CEM), and image-guided biopsy. The company's solutions are utilized globally in screening centers and hospitals for the early detection and diagnosis of breast cancer. IMS Giotto maintains a strong focus on research and development, collaborating with academic institutions to advance imaging technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMS Giotto.